Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 7/20 | 0.38 |
| ▸ | BRD2 | P25440 | 1/20 | 0.38 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.38 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14090837 | 0.90 | BRD4 (0.49) | BRD4BRD2BRD3BRDTKDM4E | |
| SCHEMBL14090857 | 0.86 | NPSR1 (0.36) | KDM4EALDH1A1SMN1; SMN2PAX8TDP1 | |
| SCHEMBL14090861 | 0.83 | NPSR1 (0.42) | BRD4BRD2BRD3BRDTKDM4E | |
| SCHEMBL14090856 | 0.82 | C3AR1 (0.40) | BRD4KDM4EALDH1A1C3AR1PAX8 | |
| SCHEMBL14090845 | 0.82 | BRD4 (0.53) | BRD4PDPK1BRD2BRD3BRDT | |
| SCHEMBL4993059 | 0.80 | C3AR1 (0.51) | BRD4PDPK1BRD2BRD3BRDT | |
| SCHEMBL14090883 | 0.79 | BRD4 (0.52) | BRD4PDPK1BRD2BRD3BRDT | |
| SCHEMBL4986504 | 0.79 | BRD4 (0.58) | BRD4BRD2BRD3BRDTKDM4E | |
| SCHEMBL14090936 | 0.78 | BRD4 (0.50) | BRD4BRD2BRD3BRDTKDM4E | |
| SCHEMBL14090868 | 0.77 | NPSR1 (0.36) | PDPK1KDM4EALDH1A1PAX8TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | ENCYSIVE PHARMACEUTICALS, INC. | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | C3AR1, C5, C5AR1 | BRD4 2776/4885PDPK1 2942/4885BRD2 4008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.